WallStreetZenWallStreetZen

NASDAQ: NBTX
Nanobiotix Sa Earnings & Revenue

NBTX past revenue growth

How has NBTX's revenue growth performed historically?
Company
691.8%
Industry
90.19%
Market
19.07%
NBTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NBTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NBTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NBTX earnings and revenue history

Current Revenue
$40.2M
Current Earnings
-$44.1M
Current Profit Margin
-109.6%

NBTX Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when NBTX announces earnings.

NBTX Return on Assets

Current Company
-51.7%
Current Industry
2.9%
NBTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NBTX Return on Capital Employed

Current Company
-56.28%
Current Industry
19.5%
NBTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NBTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NBTX$38.93M-$25.02M-$42.69M+58.68%N/A
NKTR$90.17M-$144.43M-$175.84M-40.25%N/A
CRMD$0.00-$51.52M-$50.24M-100.00%N/A
ZVRA$28.01M-$46.33M-$50.90M+17.04%N/A
FHTX$33.90M-$80.43M-$92.95M+359.19%N/A

Nanobiotix Sa Earnings & Revenue FAQ

What were NBTX's earnings last quarter?

Nanobiotix Sa (NASDAQ: NBTX) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Nanobiotix Sa earnings for the quarter were N/A. In the same quarter last year, Nanobiotix Sa's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Nanobiotix Sa stock.

What was NBTX's earnings growth in the past year?

As of Q3 2024, Nanobiotix Sa's earnings has grown year over year. Nanobiotix Sa's earnings in the past year totalled -$42.69 million.

What was NBTX's revenue last quarter?

Nanobiotix Sa (NASDAQ: NBTX) reported Q4 2023 revenue of N/A up N/A year over year. In the same quarter last year, Nanobiotix Sa's revenue was N/A.

What was NBTX's revenue growth in the past year?

As of Q3 2024, Nanobiotix Sa's revenue has grown 691.8% year over year. This is 601.61 percentage points higher than the US Biotechnology industry revenue growth rate of 90.19%. Nanobiotix Sa's revenue in the past year totalled $38.93 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.